FDA Clearance Tracker · P150038-S022
Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)
Last checked: Nov 20, 2026Latest source record: Dec 8, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 8, 2022
Approved
Time to decision
177 days
Received Jun 14, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150038-S022
- Device name
- Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)
- Applicant
- Insightec
- Applicant location
- Tirat Carmel
- Received
- Jun 14, 2022
- Decided
- Dec 8, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P150038
Device type
- Device type
- MR-guided focused ultrasound system (POH)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval for labeling changes to the indications for use of the device in idiopathic Essential tremor patients with medication-refractory tremor.
Source documents
Other decisions for Insightec
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Exablate Model 4000 Type-1 SystemPMA supplement
P150038-S037 · Decided Jul 3, 2025 · 352 days after receipt · Panel Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.